Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 FY- Text added to 2022 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
acute, ADCC, agent, amplify, attenuate, augment, Aurigene, bidding, biomarker, Biotech, Breyanzi, bulk, CA, cetuximab, chemoradiation, closure, coupled, daratumumab, darvulamab, darvulumab, disagree, epidemic, facilitate, feedback, frequency, furniture, gamma, gap, geopolitical, immunomodulatory, immunoregulatory, inflammatory, inhibitory, interchangeability, interchangeable, interferon, invasion, IRA, Knight, Kyvema, leukemia, lymphoblastic, mistakenly, nondeductible, notified, oversee, percent, persistency, pressure, PROPEL, Quell, real, rebalance, reform, repatriate, repatriation, restrain, retaliatory, rezpegaldesleukin, Sangamo, seasoned, Sonoma, SOTIO, specialist, sublet, subtenant, Taxpayer, TNF, turnover, TxCell, unparalleled, vacant, vendor, wound, wrong, Yescarta
Removed:
abscopal, Adaptimmune, Advancement, advantage, ADVATE, age, aged, aggregated, amphiphilic, analogized, Anaveon, annum, antagonist, antigen, antigenicity, antihemophilic, antiviral, Apeiron, applied, aptamer, Armo, array, assigned, assured, attach, Authorisation, axial, axitinib, BAX, Berkeley, beta, biasing, bioactivity, biodistribution, blood, branched, broader, Brooklyn, built, Canada, capitalizing, Celgene, Celltech, certoluzimab, challenged, chart, chimeric, Chiroscience, cisplatin, classic, clear, clinic, closely, clotting, collaborated, collaborating, combined, combining, complementary, compound, conform, conjugated, construct, convey, County, creditable, critically, crystallizable, customized, cytokine, cytotoxic, dapriolizumab, deduct, deficiency, degradable, dendritic, differential, disadvantage, discover, dismissed, disorder, domain, dosing, dysfunction, earned, EC, educate, efficient, ema, emerging, enabled, endothelial, enhanced, entirety, epidemiological, explore, explored, exploring, Eyetech, Fab, Fc, fifteen, filtration, Finally, fragment, frequent, FVIII, gastrointestinal, Genentech, genetic, Germany, gil, Gilead, GlaxoSmithKline, globally, glomerular, goal, Goodrich, gram, grow, guaranteeing, hormone, Hyderabad, Iceland, immunostimulatory, ineligible, infiltrating, inflamed, inhibit, insolvency, intensive, internally, Japan, Jassen, kill, Kite, labrucherie, leader, leading, leverage, Lexicon, Liechtenstein, linkage, LMS, maturation, mature, membrane, missed, missing, modulate, modulated, monoclonal, mutual, narrower, neoantigen, newer, Norway, noted, NSCLC, nurse, observational, OIC, older, oncolytic, opioid, opposing, optimally, optimized, orally, overcome, PAMORA, parent, pathological, payroll, pediatric, peptide, personalized, Pharmacia, pharmacokinetic, pharmacologic, pharmacological, Philogen, physicochemical, plc, potency, pound, prepared, prescribe, programmed, project, promote, ProStrakan, psoriatic, putative, qualifying, ranging, rapid, ratio, rational, rationale, RCC, reclassified, recommended, recurring, regression, releasable, repay, repayment, retained, REVEAL, rFVIII, rolling, Rosati, rounding, simultaneously, SITC, situation, slower, soluble, Sonsini, sourced, Specialty, spite, stable, sterling, strain, strong, subunit, successive, summer, surface, surgical, Switzerland, synergistic, Targazyme, taxable, Tesaro, TIL, today, Tracking, train, treating, trued, unaudited, untreated, uptake, Vaccibody, vaccine, versatile, water, widespread, Xavier
Valuein 2021 FY filing- Value in 2022 FY filing
Original filings
Filing view